Is Open-Capsule Proton Pump Inhibitor Associated with Faster Healing Time for Marginal Ulceration After Roux-en-Y Gastric Bypass?

Marginal ulceration (MU) is a significant cause of morbidity after Roux-en-Y gastric bypass (RYGB). Proton pump inhibitors (PPI) are the primary treatment. Prior limited data suggest that open-capsule PPI (OC-PPI) improves MU healing compared to intact-capsule PPI (IC-PPI), necessitating further validation.

Source: Surgery for Obesity and Related Diseases - October 13, 2023 Category: Surgery Authors: Heesoo Yoo, Stephen A. Firkins, Alvin Kwon, Kristelle Imperio-Lagabon, Ramanpreet Bajwa, Bailey Flora, C. Roberto Simons-Linares Tags: Original articles Source Type: research